AGIO vs CCI · rev $65.5M vs P/E 40, rev $2.02B
Agios Pharm (AGIO) versus Crown Castle (CCI) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
Crown Castle (CCI) is a reit - specialty company listed on US.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Latest reported CCI revenue for 2026-06-30 was $2.02B. Net income was $245.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
AGIO currently screens at market cap $1.68B. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Not investment advice. Open the AGIO and CCI stock pages for the full models.
Not investment advice.